Article summary
The Department of Health and Social Care (DHSC) has announced that the UK has agreed a contract for 35 million more doses of the Pfizer/BioNTech vaccine to 'future-proof' the country from the threat of coronavirus (COVID-19) and its variants. The vaccines, which will be delivered from the second half of 2022, are to cover any future booster programme. The booster programme will be based on the final advice of the Joint Committee on Vaccination and Immunisation, which is expected in September 2021. The agreement was made through the Vaccine Taskforce, which has contracts in place with multiple vaccine manufacturers.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial